Still does not invalidate the fact that 70-80% of the API raw materials that Indian pharma uses is imported from China.
China can raise API prices unilaterally or even block them from Indian shores - killing Indian Pharma. And this is without the double whammy of Trump's threatened tariffs for Indian Pharma imports to the US.
Pharma Industry insiders in India are all unanimous about it - and you are not.
Is this a vulnerability for India - yes or no?
@Jiangnan what do Chinese API manufacturing insiders say about it?
Can India Reclaim API Throne from China?
www.biospectrumindia.com